We are live on ! Find out more
CLOV icon

Clover Health Investments

175 hedge funds and large institutions have $210M invested in Clover Health Investments in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $7.99M | Put options by funds: $4.94M

49% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

0.09% less ownership

Funds ownership: 32.28%32.19% (-0.09%)

1% less funds holding

Funds holding: 176175 (-1)

20% less capital invested

Capital invested by funds: $262M → $210M (-$52.5M)

Holders
175
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3.01%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
25
Increased
58
Reduced
39
Closed
25
Calls
$7.99M
Puts
$4.94M
Net Calls
+$3.05M
Net Calls Change
-$3.58M
Name Holding Trade Value Shares
Change
Change in
Stake
AB
76
Amalgamated Bank
New York
$105K +$3.98K +1,521 +3%
HSBC Holdings
77
HSBC Holdings
United Kingdom
$96K -$22.9K -8,754 -14%
Baird Financial Group
78
Baird Financial Group
Wisconsin
$92K -$5 -2 -0%
SWM
79
SeaCrest Wealth Management
New York
$83K
Cambridge Investment Research Advisors
80
Cambridge Investment Research Advisors
Iowa
$79K -$26K -9,923 -18%
Teacher Retirement System of Texas
81
Teacher Retirement System of Texas
Texas
$79K +$1.48K +563 +1%
Zurich Cantonal Bank
82
Zurich Cantonal Bank
Switzerland
$76K
TRCT
83
Tower Research Capital (TRC)
New York
$73K -$177K -67,686 -61%
ProShare Advisors
84
ProShare Advisors
Maryland
$73K -$733 -280 -0.7%
Handelsbanken Fonder
85
Handelsbanken Fonder
Sweden
$72K
Wells Fargo
86
Wells Fargo
California
$70K -$41.5K -15,826 -28%
PLU
87
Performa Ltd (US)
South Carolina
$66K -$2.62K -1,000 -3%
Victory Capital Management
88
Victory Capital Management
Texas
$64K +$99.2K +37,859 New
DFCM
89
Dark Forest Capital Management
Puerto Rico
$60K +$91.8K +35,058 +292,150%
QI
90
Qtron Investments
Massachusetts
$59K -$1.31K -502 -1%
American Century Companies
91
American Century Companies
Missouri
$59K +$60.8K +23,195 +207%
HSA
92
HBK Sorce Advisory
Pennsylvania
$56K +$524 +200 +0.6%
CG
93
Cutler Group
California
$56K +$9.79K +3,739 +13%
SM
94
Skaana Management
New York
$55K
PHK
95
Point72 Hong Kong
Hong Kong
$54K +$65.4K +24,960 +375%
CAPTRUST Financial Advisors
96
CAPTRUST Financial Advisors
North Carolina
$53K +$79.5K +30,364 +2,788%
VCM
97
Viewpoint Capital Management
Washington
$52K
QP
98
Quilter Plc
United Kingdom
$52K +$79.8K +30,479 New
TCBWMS
99
Texas Capital Bank Wealth Management Services
Texas
$51K
AG
100
Algert Global
California
$49K +$75.1K +28,689 New

CLOV Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q3 2022, worth a combined $210M — down 20% from $262M a quarter earlier.

Fund positioning in CLOV was balanced in Q3 2022: 25 funds opened new positions, 25 closed out, 58 added to existing stakes and 39 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $6.16M. The largest seller was Two Sigma Advisers, cutting an estimated $5.66M.

  • 175 institutional investors held Clover Health Investments (CLOV) as of Q3 2022, down from 176 in Q2 2022.
  • Funds reported $210M of Clover Health Investments stock for Q3 2022, down 20% quarter-over-quarter.
  • 25 funds opened new Clover Health Investments positions in Q3 2022 and 25 closed out, a net change of 0 holders.
  • The largest Clover Health Investments buyer in Q3 2022 was Renaissance Technologies, an estimated $6.16M added.
  • The largest Clover Health Investments seller in Q3 2022 was Two Sigma Advisers, an estimated $5.66M sold.

Based on aggregated 13F filings for Q3 2022.